MedTrace Logo

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

NCT01406431 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2013-01-03

No results posted yet for this study

Summary

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

Conditions

Interventions

DRUG

Pitavastatin, Valsartan

Pitavastatin 4mg(2 tablets), Valsartan 160mg(1 tablet)

DRUG

Livalo® fixed combination drug

Livalo® fixed combination drug(1 tablet)

Sponsors & Collaborators

Principal Investigators

  • Kyun Seop Bae, MD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-08-31
Completion
2012-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01406431 on ClinicalTrials.gov